Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02514447
Title Study of G1T28 in Patients With Previously Treated Extensive Stage SCLC Receiving Topotecan Chemotherapy
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors G1 Therapeutics, Inc.
Age Groups: adult
Covered Countries USA | BEL

No variant requirements are available.